Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day, everyone. My name is Ashley and I will be your ...

Abstract: Systems, eye-mountable devices, and methods that facilitate chronotherapeutic treatment of primary open-angle ...

A tenacious but troubled Washington, D.C. police detective investigates a serial killing spree that may or may not be connected to a case from his own past.

Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the company's ...